Injectable semaglutide is typically administered once a week, which can be more convenient for those who prefer less frequent dosing
Helpful Tools Related Articles Retatrutide Availability & Timeline Retatrutide is expected to receive FDA approval in mid-2027 with pharmacy availability in late 2027
Hamad, Youssef El-Sayed, Nagwa Mahmoud Ramadan, Journal of Drug Delivery Science and Technology.2026
Infection Risk: Like any shot, there is a tiny risk of infection if the area is not kept sterile
So then I feel like I was like, like, just busy and I was like, okay, I just gotta get to the next thing
Sustained Results : Studies have indicated that the use of GLP-1 medication can result in sustained weight loss over an extended period, offering long-term benefits for individuals seeking to manage obesity